background
ASM 2014 General Meeting
Evaluation of Verigene (Nanosphere, Inc.) Gram-Negative Bacteria Blood Culture Nucleic Acid Test (BC-GN) RUO
Decreasing Turnaround Times in Septic Patients Infected with Carbapenemase Producing Gram Negative Organisms, a First Look at an Emerging Technology
Evaluation of the Nanosphere-Verigene GN-BC for the Identification of Gram Negative Bacilli and Detection of Antibiotic Resistance Mechanisms Directly from Positive Blood Cultures
Comparison of Verigene BC-GP to Peptide Nucleic Acid Fluorescence in situ Hybridization (PNA-FISH) in Conjunction with mecA Gene Detection for Staphylococcus aureus Bacteremia
Performance of the Nanosphere Verigene BC-GN Assay in an Acute Care Inner-City Hospital
Comparison of Three Multiplex Platforms for the Detection of Respiratory Tract Viruses
Evaluation of the Verigene Gram-Negative Blood Culture Test (BC-GN) IUO
Effects of Blood Volume on the Performance of the Verigene BC-GP Assay in Pediatric Patients
Verigene BC-GN Test for Rapid Detection of Gram-Negative Bacteria from Positive Blood Cultures in Pediatric Inpatients: A Multi-Center Evaluation
Pages
